HTG Molecular Diagnostics Inc (HTGM.OQ)
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|64||2017||Independent Chairman of the Board|
|55||2008||President, Chief Executive Officer, Director|
|55||2012||Vice President of Finance and Administration, Chief Financial Officer|
|64||2014||Senior Vice President - Research and Product Development|
|57||2016||Vice President, Chief Legal Counsel and Secretary|
- BRIEF-HTG Molecular Diagnostics Announces Completion Of Public Offering Of Common Stock
- BRIEF-Stonepine Capital Management Reports 5.6 Pct Passive Stake In HTG Molecular Diagnostics
- BRIEF-HTG Molecular Diagnostics Announces Pricing Of Public Offering Of Common Stock
- BRIEF-HTG Molecular Diagnostics Expects Q4 2017 Revenue of $7.6 Mln to $7.9 Mln- SEC Filing
- BRIEF-HTG Molecular Diagnostics Intends To Offer 10 mln shares of common stock